Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours Β· Estimated delivery Oct 8 - Oct 13
European Journal of Pharmacology, 869 , 172891
Researchers discovered it in the 1990s while studying how the stomach protects itself from acid damage
At present: There is no FDA approval There is no standard prescription pathway There is no approved supplement classification There is no lawful retail medical distribution model The only compliant framework that exists today is legitimate research distribution , meaning: Supplied for scientific investigation Not sold as treatment Not administered to patients Not marketed for healing or recovery Anything else blurs into non-compliance
It is studied for its body protection, tissue repair, and cytoprotection properties, with research focusing on its ability to support and repair bodily tissues, maintain vascular integrity, and promote healing
AOD-9604 specifically targets fat metabolism without affecting blood sugar or insulin pathways, making it theoretically useful for patients who experience gastrointestinal side effects from GLP-1 medications like Semaglutide
